Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Deficiency may result in fatigue, weakness, a sore, red tongue or mouth ulcers
A PCAC review is scheduled for July 2026, and multiple compounding groups have petitioned for Category 1 reclassification, citing the 2025 IV safety pilot (PMID 40131143) and growing clinical experience
The lyophilized form supports stability, accurate dissolution, and repeatable handling when used with appropriate sterile solvents in controlled experimental procedures
Early detection of potential FOXO4-DRI side effects allows for prompt adjustment of protocols, safeguarding both the research subject and the integrity of your study
Schedule a visit to review your wellness goals, available injection options, medical history, allergies, and pricing with our clinical team
Fischer,
US$ 21.15
US$ 26.64
US$ 29.10
US$ 21.96
US$ 22.79
US$ 24.48
US$ 20.75
